|
|
10060 Carroll Canyon Rd, Suite 100
San Diego, CA 92131 USA
phone:858.695.8118
fax:
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
2004 |
| Employees |
|
|
|
| www.BeneChill.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Non-invasive cooling technology for the treatment of cerebral ischemia. |
|
| Management |
| Denise Barbut MBBS. MD. MRCP., Founder and CEO; Allan Rozenberg, Ph.D., Chief Operating Officer; |
| |
|
|
| |
|
| Keywords |
| non-invasive, cooling, cerebral ischemia, adv2007 |
|
|
|
| Description |
|
BeneChill is developing non-invasive regional cooling technology for the treatment of cerebral ischemia. |
|
| Products / Services |
The RhinoChill System initiates and provides therapeutic cooling with limited delays. It is non-invasive, easy-to-use, portable, and requires no external power.
|
|
| Technology / Differentiation |
| The RhinoChill System uses the nasal cavity for cooling. This is advantageous due to the nasal cavity being:
*A natural orifice into the body
*In close proximity to the brain
*A natural heat exchanger
Use of the nasal cavity enables treatment by non-specialized medical personnel using non-sterile technique in any environment. |
|
| Market / Customers |
BeneChill's technology facilitates targeted cooling in field, ambulance, ER and general hospital environments.
|
|
| Funding |
| The company is currently raising 20 million dollars to complete the pivital study to seek FDA approval. |
|
| Status |
| BeneChill is currently enrolling patients in clinical studies of the RhinoChill System in the United States and Europe.
The company has recieved CE mark and is currently conducting a pivital study necessary for FDA approval. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members